Miethke, Marcus
Pieroni, Marco
Weber, Tilmann https://orcid.org/0000-0002-8260-5120
Brönstrup, Mark
Hammann, Peter
Halby, Ludovic
Arimondo, Paola B.
Glaser, Philippe
Aigle, Bertrand https://orcid.org/0000-0001-5266-5926
Bode, Helge B. https://orcid.org/0000-0001-6048-5909
Moreira, Rui
Li, Yanyan
Luzhetskyy, Andriy
Medema, Marnix H. https://orcid.org/0000-0002-2191-2821
Pernodet, Jean-Luc https://orcid.org/0000-0002-6129-7093
Stadler, Marc
Tormo, José Rubén
Genilloud, Olga
Truman, Andrew W. https://orcid.org/0000-0001-5453-7485
Weissman, Kira J. https://orcid.org/0000-0002-3012-2960
Takano, Eriko https://orcid.org/0000-0002-6791-3256
Sabatini, Stefano https://orcid.org/0000-0003-0971-3536
Stegmann, Evi
Brötz-Oesterhelt, Heike
Wohlleben, Wolfgang
Seemann, Myriam https://orcid.org/0000-0002-2615-1574
Empting, Martin
Hirsch, Anna K. H.
Loretz, Brigitta
Lehr, Claus-Michael
Titz, Alexander https://orcid.org/0000-0001-7408-5084
Herrmann, Jennifer
Jaeger, Timo
Alt, Silke
Hesterkamp, Thomas
Winterhalter, Mathias https://orcid.org/0000-0002-1604-3318
Schiefer, Andrea https://orcid.org/0000-0002-9823-2090
Pfarr, Kenneth https://orcid.org/0000-0003-3096-2465
Hoerauf, Achim
Graz, Heather
Graz, Michael https://orcid.org/0000-0003-0818-2614
Lindvall, Mika
Ramurthy, Savithri
Karlén, Anders
van Dongen, Maarten
Petkovic, Hrvoje
Keller, Andreas https://orcid.org/0000-0002-5361-0895
Peyrane, Frédéric
Donadio, Stefano
Fraisse, Laurent
Piddock, Laura J. V. https://orcid.org/0000-0003-1460-473X
Gilbert, Ian H. https://orcid.org/0000-0002-5238-1314
Moser, Heinz E. https://orcid.org/0000-0002-8013-2139
Müller, Rolf https://orcid.org/0000-0002-1042-5665
Article History
Accepted: 1 July 2021
First Online: 19 August 2021
Competing interests
: M. H. Medema is a co-founder of Design Pharmaceuticals and a member of the scientific advisory board of Hexagon Bio, and S. Donadio is a co-founder and shareholder of NAICONS, owning intellectual property on antibacterial compounds. The remaining authors do not declare any competing interests.
Free to read: This content has been made available to all.